These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27261521)

  • 1. Parametric Binding Images of the TSPO Ligand 18F-DPA-714.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Te Beek ET; Groeneveld GJ; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Nucl Med; 2016 Oct; 57(10):1543-1547. PubMed ID: 27261521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients.
    Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO
    J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.
    Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D
    Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
    Schuitemaker A; van Berckel BN; Kropholler MA; Kloet RW; Jonker C; Scheltens P; Lammertsma AA; Boellaard R
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1603-15. PubMed ID: 17311080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability of parametric methods for [
    Verfaillie SC; Golla SS; Timmers T; Tuncel H; van der Weijden CW; Schober P; Schuit RC; van der Flier WM; Windhorst AD; Lammertsma AA; van Berckel BN; Boellaard R
    J Cereb Blood Flow Metab; 2021 Mar; 41(3):569-578. PubMed ID: 32321347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of
    Wimberley C; Lavisse S; Brulon V; Peyronneau MA; Leroy C; Bodini B; Remy P; Stankoff B; Buvat I; Bottlaender M
    J Nucl Med; 2018 Feb; 59(2):307-314. PubMed ID: 28775204
    [No Abstract]   [Full Text] [Related]  

  • 14. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
    Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714.
    Cacheux F; Médran-Navarrete V; Dollé F; Marguet F; Puech F; Damont A
    Eur J Med Chem; 2017 Jan; 125():346-359. PubMed ID: 27688189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain.
    Lavisse S; Inoue K; Jan C; Peyronneau MA; Petit F; Goutal S; Dauguet J; Guillermier M; Dollé F; Rbah-Vidal L; Van Camp N; Aron-Badin R; Remy P; Hantraye P
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
    Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
    Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.